The amount Medicare reimburses providers for medical services per beneficiary is more than twice as high in some markets, even when differences in the price of services in some areas are considered. While the prices for services vary dramatically from one market to the next, the study showed no evidence that patients in one area of the country are in better or worse health than those in another area. Back To Index 11. More AIDS patients to try controversial blood scalding. The Food and Drug Administration will let IDT Inc. add 60 AIDS patients to its trial, where patient's blood is drained, heated to 114 degrees and steamed back in.
Blood continues to circulate during the process.
But the FDA cautioned that nobody has proved this treatment helps AIDS patients. The early trials merely showed that IDT could heat patients' blood, bringing their overall body temperature to almost 108 degrees, without causing brain damage or other harm, said FDA's Dr. Susan Alpert. Some U.S. AIDS patients who then turned to attempts in other countries died. Back To Index 12. Proves Promising In Preliminary Trial.